'Cures' adopted; mandatory NIH, FDA funds survive challenge
This article was originally published in Scrip
Executive Summary
In a 344-77 vote on 10 July, the US House passed legislation intended to overhaul the US biomedical enterprise, with the aim of accelerating the discovery, development and approval processes for medical products – the 21st Century Cures Act (HR 6).